Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.

[1]  G. Caignard,et al.  Re‐Emergence of Bluetongue Virus Serotype 8 in France, 2015 , 2017, Transboundary and emerging diseases.

[2]  H. Attoui,et al.  Complete Genome Sequence of Bluetongue Virus Serotype 8, Which Reemerged in France in August 2015 , 2016, Genome Announcements.

[3]  A. Lorusso,et al.  Innocuity of a commercial live attenuated vaccine for epizootic hemorrhagic disease virus serotype 2 in late-term pregnant cows. , 2016, Vaccine.

[4]  S. Zientara,et al.  Viral emergence and consequences for reproductive performance in ruminants: two recent examples (bluetongue and Schmallenberg viruses). , 2015, Reproduction, fertility, and development.

[5]  Alban Thomas,et al.  Cost assessment of the movement restriction policy in France during the 2006 bluetongue virus episode (BTV-8). , 2014, Preventive veterinary medicine.

[6]  Hans-Joachim Baetza.  Eradication of bluetongue disease in Germany by vaccination. , 2014, Veterinary immunology and immunopathology.

[7]  A. Lorusso,et al.  Bluetongue virus serotypes 1 and 4 in Sardinia during autumn 2012: new incursions or re-infection with old strains? , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[8]  J. Sánchez-Vizcaíno,et al.  Control of bluetongue in Europe. , 2013, Veterinary microbiology.

[9]  H. Seegers,et al.  Decrease in milk yield associated with exposure to bluetongue virus serotype 8 in cattle herds. , 2013, Journal of dairy science.

[10]  K. De Clercq,et al.  The presence of bluetongue virus serotype 8 RNA in Belgian cattle since 2008. , 2011, Transboundary and emerging diseases.

[11]  C. Ducrot,et al.  Estimating front-wave velocity of infectious diseases: a simple, efficient method applied to bluetongue , 2011, Veterinary research.

[12]  B. Hoffmann,et al.  Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats. , 2011, Vaccine.

[13]  A. Giovannini,et al.  Bluetongue control strategy, including recourse to vaccine: a critical review. , 2010, Revue scientifique et technique.

[14]  J. Sánchez-Vizcaíno,et al.  Bluetongue vaccination in Europe , 2010, Expert review of vaccines.

[15]  M. Beer,et al.  Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. , 2010, Vaccine.

[16]  A. Giovannini,et al.  Antibody response in cattle vaccinated against bluetongue serotype 8 in Italy. , 2010, Transboundary and Emerging Diseases.

[17]  H W Saatkamp,et al.  Financial consequences of the Dutch bluetongue serotype 8 epidemics of 2006 and 2007. , 2010, Preventive veterinary medicine.

[18]  E. Thiry,et al.  Bovine infection with bluetongue virus with special emphasis on European serotype 8. , 2009, Veterinary journal.

[19]  F. Conraths,et al.  Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. , 2009, Vaccine.

[20]  K. De Clercq,et al.  Bluetongue in Belgium: episode II. , 2009, Transboundary and emerging diseases.

[21]  M. Hofmann,et al.  Genetic Characterization of Toggenburg Orbivirus, a New Bluetongue Virus, from Goats, Switzerland , 2008, Emerging infectious diseases.

[22]  G. Gerbier,et al.  Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands. , 2008, Preventive veterinary medicine.

[23]  Guy Hendrickx,et al.  Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. , 2008, Preventive veterinary medicine.

[24]  C. Saegerman,et al.  Bluetongue Epidemiology in the European Union , 2008, Emerging infectious diseases.

[25]  J. Sánchez-Vizcaíno,et al.  Vaccines against bluetongue in Europe. , 2008, Comparative immunology, microbiology and infectious diseases.

[26]  B. Bonfini,et al.  Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2. , 2007, Veterinaria italiana.

[27]  E. Thiry,et al.  Bluetongue in northern Europe , 2006, Veterinary Record.

[28]  A. Giovannini,et al.  Bluetongue vaccination in Europe: the Italian experience. , 2004, Veterinaria italiana.

[29]  F. Monaco,et al.  Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2. , 2004, Veterinaria italiana.

[30]  F. Monaco,et al.  Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows. , 2004, Veterinaria italiana.

[31]  J. Stott,et al.  Inactivated bluetongue virus vaccine in lambs: Differential serological responses related to breed , 1981, Veterinary Research Communications.

[32]  R. Sellers,et al.  An experimental inactivated vaccine against bluetongue , 1975, Veterinary Record.

[33]  Eric Chicken,et al.  Nonparametric Statistical Methods: Hollander/Nonparametric Statistical Methods , 1973 .

[34]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[35]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.